Compugen Ltd. (USA)
General ticker "CGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $139.8M
Compugen Ltd. (USA) does not follow the US Stock Market performance with the rate: -15.2%.
Estimated limits based on current volatility of 3.1%: low 1.47$, high 1.56$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.14$, 2.31$]
- 2024-12-30 to 2025-12-30 estimated range: [1.08$, 2.20$]
Short-term CGEN quotes
Long-term CGEN plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $33.46MM |
| Operating Expenses | $46.45MM |
| Operating Income | $-12.99MM |
| Non-Operating Income | $3.21MM |
| Interest Expense | $0.03MM |
| R&D Expense | $34.47MM |
| Income(Loss) | $-9.78MM |
| Taxes | $8.97MM |
| Profit(Loss) | $-18.75MM |
| Stockholders Equity | $65.56MM |
| Assets | $121.33MM |
| Operating Cash Flow | $-35.89MM |
| Capital expenditure | $0.17MM |
| Investing Cash Flow | $35.51MM |
| Financing Cash Flow | $3.08MM |
| Earnings Per Share* | $-0.21 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.